Camurus AB (FRA:7CA) E10: €0.01 (As of Mar. 2026)


FRA:7CA Camurus AB FRA:7CA
84 GF Score
Price €49.58
GF Value €62.28
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Camurus AB E10?

Camurus AB FRA:7CA +1.81% 84 E10 is €0.01 as of Mar. 2026. GuruFocus rates FRA:7CA with a GF Score™ of 84/100 and a GF Value™ of €62.28 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Camurus AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.223. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.01 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-29), Camurus AB's current stock price is €49.58. Camurus AB's E10 for the quarter that ended in Mar. 2026 was €0.01. Camurus AB's Shiller PE Ratio of today is 4,958.00.

During the past 13 years, the highest Shiller PE Ratio of Camurus AB was 3860.00. The lowest was 3224.00. And the median was 3540.00.


Camurus AB  (FRA:7CA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Camurus AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=49.58/0.01
=4,958.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Camurus AB was 3860.00. The lowest was 3224.00. And the median was 3540.00.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Camurus AB E10 Related Terms


Camurus AB E10 Historical Data

* Premium members only.

The historical data trend for Camurus AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB E10 Chart

Camurus AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.24 -0.18 -0.01

Camurus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -0.07 -0.04 -0.01 0.01

FRA:7CA vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Camurus AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's Shiller PE Ratio falls into.


FRA:7CA
84GF Score
Camurus AB FRA:7CA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camurus AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Camurus AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.223/133.3862*133.3862
=0.223

Current CPI (Mar. 2026) = 133.3862.

Camurus AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.054 101.019 -0.071
201609 -0.033 101.138 -0.044
201612 -0.070 102.022 -0.092
201703 -0.104 102.022 -0.136
201706 -0.115 102.752 -0.149
201709 -0.134 103.279 -0.173
201712 -0.129 103.793 -0.166
201803 -0.095 103.962 -0.122
201806 -0.176 104.875 -0.224
201809 -0.102 105.679 -0.129
201812 -0.207 105.912 -0.261
201903 -0.154 105.886 -0.194
201906 -0.160 106.742 -0.200
201909 -0.123 107.214 -0.153
201912 -0.140 107.766 -0.173
202003 -0.109 106.563 -0.136
202006 -0.037 107.498 -0.046
202009 -0.036 107.635 -0.045
202012 -0.121 108.296 -0.149
202103 -0.039 108.360 -0.048
202106 -0.088 108.928 -0.108
202109 -0.011 110.338 -0.013
202112 -0.024 112.486 -0.028
202203 -0.001 114.825 -0.001
202206 0.013 118.384 0.015
202209 0.056 122.296 0.061
202212 0.021 126.365 0.022
202303 0.091 127.042 0.096
202306 0.449 129.407 0.463
202309 0.127 130.224 0.130
202312 -0.024 131.912 -0.024
202403 0.117 132.205 0.118
202406 0.111 132.716 0.112
202409 0.190 132.304 0.192
202412 0.213 132.987 0.214
202503 0.302 132.825 0.303
202506 0.370 133.699 0.369
202509 0.290 133.482 0.290
202512 0.153 133.386 0.153
202603 0.223 133.386 0.223

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.01 mean?
Camurus AB (FRA:7CA) has a E10 of €0.01 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Camurus AB and its competitors.
Is Camurus AB's E10 too high?
Camurus AB's current E10 is €0.01. Overall, Camurus AB has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's E10 compare to VRTX and REGN?
Camurus AB's E10 of €0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Camurus AB and its competitors. Camurus AB's current E10 is €0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (FRA:7CA) is currently considered Modestly Undervalued. The stock's GF Value™ is €62.28, compared to a current price of €49.58 — trading 20.4% below its estimated fair value. The current E10 is €0.01. Camurus AB's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Camurus AB (FRA:7CA), the current E10 is €0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Camurus AB (FRA:7CA) Overvalued in 2026?

Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued. The current stock price of €49.58 is trading 20.4% below its estimated GF Value™ of €62.28. GuruFocus considers Camurus AB to be Modestly Undervalued.

Key valuation signals for FRA:7CA:

  • E10: €0.01
  • GF Value™: €62.28 vs. price of €49.58 (20.4% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the FRA:7CA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Camurus AB Business Description

Address Rydbergs torg 4, Lund, SWE, SE-224 84
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
84GF Score

Get the complete analysis for FRA:7CA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.58
Price
€62.28
GF Value